HeartSciences (HSCS) Shares Outstanding (Weighted Average) (2021 - 2026)

HeartSciences has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 135.18% year-over-year to $2.1 million; the trailing twelve-month figure through Jan 2026 stood at $2.1 million (up 135.18% YoY), and the FY2025 full-year result was $938257.0, up 166.16% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $2.1 million, roughly flat from $2.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $8.2 million in Q1 2023, with the low at $79506.0 in Q2 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $2.2 million across 5 years, with a median of $917445.0 in 2024.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) slumped 98.46% — and 2024, when it surged 760.79%.
• HeartSciences' Shares Outstanding (Weighted Average) stood at $6.9 million in 2022, then tumbled by 98.46% to $106582.0 in 2023, then surged by 760.79% to $917445.0 in 2024, then jumped by 128.57% to $2.1 million in 2025, then increased by 0.27% to $2.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.